Automated insulin delivery improves glycemic control of type 2 diabetes in randomized trial

Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery (AID) in adults with insulin-treated type 2 diabetes. AID significantly lowered glycated hemoglobin (HbA1c) levels and improved glucose control compared to standard insulin therapy with continuous glucose monitoring (CGM).

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup